• We are a biotech company in
    infectious diseases with a
    first marketed product.

  • We are dedicated to
    innovation in antibody
    discovery and vaccine R&D.

  • Valneva covers the full
    value chain from bench
    to market.

Welcome to Valneva

Joining forces to create a European biotech leader in vaccines and antibodies


— News, April 10, 2014

Valneva and Adimmune partner to commercialize Japanese Encephalitis vaccine in Taiwan
Download PR

— Stock information



—News, March 24, 2014

Valneva Announces the First Ever Marketing Authorization for a Human Vaccine Produced in the EB66® Cell Line

 All News

— Financial calendar

May 13, 2014
Q1 2014 Results

 All dates

March 24, 2014
Valneva Reported its Annual Results 2013:
Download PR
Download Financial Statements
Download Analysts Presentation
View Webcast

— Upcoming conferences and fairs

 June 23 - 26, 2014
Bio International Convention
San Diego, US

October 13 - 15, 2014
World Vaccine Congress Europe
Brussels, Belgium

Meet our Business Development team


European biotech company with worldwide presence.

Please update your browser...